Blueberries Medical Corp.
BBRRF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.08 | 0.18 | 0.04 | 0.16 |
| FCF Yield | -14.03% | -33.82% | -35.26% | -16.48% |
| EV / EBITDA | -5.39 | -2.62 | -3.03 | -9.76 |
| Quality | ||||
| ROIC | -107.90% | -70.27% | -47.94% | -33.44% |
| Gross Margin | 34.90% | 29.22% | -7.53% | -176.91% |
| Cash Conversion Ratio | 0.69 | 0.81 | 1.00 | 0.33 |
| Growth | ||||
| Revenue 3-Year CAGR | 26.04% | 27.60% | 52.81% | – |
| Free Cash Flow Growth | 41.19% | 7.74% | 15.07% | 42.39% |
| Safety | ||||
| Net Debt / EBITDA | 0.05 | 0.66 | 0.06 | -0.09 |
| Interest Coverage | 0.00 | -5.22 | -3.73 | -3.57 |
| Efficiency | ||||
| Inventory Turnover | 1.25 | 0.78 | 20.56 | 0.00 |
| Cash Conversion Cycle | 32.29 | -159.87 | -513.66 | 242.70 |